Stella Pharma Corporation

Tokyo Stock Exchange 4888.T

Stella Pharma Corporation Revenue Per Share for the year ending March 31, 2024: USD 0.06

Stella Pharma Corporation Revenue Per Share is USD 0.06 for the year ending March 31, 2024, a -3.73% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Stella Pharma Corporation Revenue Per Share for the year ending March 31, 2023 was USD 0.06, a 103.92% change year over year.
  • Stella Pharma Corporation Revenue Per Share for the year ending March 31, 2022 was USD 0.03, a -68.46% change year over year.
  • Stella Pharma Corporation Revenue Per Share for the year ending March 31, 2021 was USD 0.09, a 0.00% change year over year.
  • Stella Pharma Corporation Revenue Per Share for the year ending March 31, 2020 was USD 0.00.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Tokyo Stock Exchange: 4888.T

Stella Pharma Corporation

CEO Mr. Koki Uehara
IPO Date April 22, 2021
Location Japan
Headquarters ORIX Kouraibashi Building
Employees 44
Sector Health Care
Industries
Pharmaceuticals Biotechnology
Description

Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was incorporated in 2007 and is headquartered in Osaka, Japan.

StockViz Staff

January 15, 2025

Any question? Send us an email